28 related articles for article (PubMed ID: 18949670)
1. Identification of candidate target antigens for antibody-based immunotherapy in childhood B-cell precursor ALL.
Gudowius S; Recker K; Laws HJ; Dirksen U; Tröger A; Wieczorek U; Furlan S; Göbel U; Hanenberg H
Klin Padiatr; 2006; 218(6):327-33. PubMed ID: 17080335
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow Th2 cytokine expression as predictor for relapse in childhood acute lymphoblastic leukemia (ALL).
Stachel D; Albert M; Meilbeck R; Kreutzer B; Haas RJ; Schmid I
Eur J Med Res; 2006 Mar; 11(3):102-13. PubMed ID: 16751110
[TBL] [Abstract][Full Text] [Related]
3. Significantly increased CD70 up regulation on TEL-AML positive B cell precursor acute lymphoblastic leukemia cells following CD40 stimulation.
Troeger A; Glouchkova L; Ackermann B; Escherich G; Hanenberg H; Janka G; Roettgers S; Göbel U; Dilloo D
Klin Padiatr; 2014 Nov; 226(6-7):332-7. PubMed ID: 25062112
[TBL] [Abstract][Full Text] [Related]
4. High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia.
Troeger A; Gudowius S; Escherich G; den Boer ML; Glouchkova L; Ackermann B; Meisel R; Laws HJ; Groeger M; Wessalowski R; Willers R; Harbott J; Pieters R; Goebel U; Janka-Schaub GE; Hanenberg H; Dilloo D
Br J Haematol; 2007 Nov; 139(3):450-7. PubMed ID: 17910636
[TBL] [Abstract][Full Text] [Related]
5. Prednisone induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B-cell precursor acute lymphoblastic leukemia cells.
Gaipa G; Basso G; Aliprandi S; Migliavacca M; Vallinoto C; Maglia O; Faini A; Veltroni M; Husak D; Schumich A; Ratei R; Biondi A; Dworzak MN;
Cytometry B Clin Cytom; 2008 May; 74(3):150-5. PubMed ID: 18271020
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts.
Troeger A; Glouchkova L; Escherich G; Siepermann M; Hanenberg H; Janka-Schaub G; Göbel U; Ackermann B; Dilloo D
Klin Padiatr; 2008; 220(6):353-7. PubMed ID: 18949670
[TBL] [Abstract][Full Text] [Related]
7. The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis?
Mason KD; Juneja SK; Szer J
Blood Rev; 2006 Mar; 20(2):71-82. PubMed ID: 16185796
[TBL] [Abstract][Full Text] [Related]
8. Acute lymphoblastic leukemia.
Onciu M
Hematol Oncol Clin North Am; 2009 Aug; 23(4):655-74. PubMed ID: 19577163
[TBL] [Abstract][Full Text] [Related]
9. Potential use of CD40 ligand for immunotherapy of childhood B-cell precursor acute lymphoblastic leukaemia.
D'Amico G; Marin V; Biondi A; Bonamino MH
Best Pract Res Clin Haematol; 2004 Sep; 17(3):465-77. PubMed ID: 15498717
[TBL] [Abstract][Full Text] [Related]
10. New genetic abnormalities and treatment response in acute lymphoblastic leukemia.
Meijerink JP; den Boer ML; Pieters R
Semin Hematol; 2009 Jan; 46(1):16-23. PubMed ID: 19100364
[TBL] [Abstract][Full Text] [Related]
11. Cytokines and microRNA in pediatric B-acute lymphoblastic leukemia.
Cocco C; Airoldi I
Cytokine Growth Factor Rev; 2011 Jun; 22(3):149-56. PubMed ID: 21764355
[TBL] [Abstract][Full Text] [Related]
12. Immature and differentiated neoplastic populations in acute lymphoid leukemia of childhood: biological and clinical implications.
Estrov Z; Re GG; Zipf TF
Leuk Lymphoma; 1993 Sep; 11(1-2):1-7. PubMed ID: 8220141
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
